Neurogene

NGNE · NASDAQ

$25.40+$1.23 (+5.09%)TodayMarket closed ·
Prev close $24.17

Who owns NGNE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.1% of NGNE’s shares.

  • Samsara BioCapital, LLC8.7%
  • Casdin Capital, LLC7.8%
  • Redmile Group, LLC7.2%
  • RTW Investments L.P.6.9%
  • Next 6 largest institutions30.5%
  • All other shareholders38.9%
Top institutional holders of NGNE
HolderShares% of shares
Samsara BioCapital, LLC1.72M8.70%
Casdin Capital, LLC1.55M7.83%
Redmile Group, LLC1.41M7.15%
RTW Investments L.P.1.36M6.90%
McMinn (Rachel L.)1.30M6.60%
EcoR1 Capital, LLC1.27M6.44%
Baker Bros. Advisors LP991.69K5.02%
BlackRock Institutional Trust Company, N.A.928.89K4.71%
Balyasny Asset Management LP818.71K4.15%
Trails Edge Capital Partners LP714.88K3.62%

Largest mutual fund holders

Top mutual fund holders of NGNE
HolderShares% of shares
Vanguard Total Stock Market Index Fund520.96K2.64%
Franklin Templeton Investment Funds -Biotechnology Discovery409.49K2.07%
Statens Pensjonsfond Utland367.19K1.86%
iShares Russell 2000 ETF295.03K1.49%
Fidelity Advisor Biotechnology Fund177.20K0.90%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $640.00K (7 trades) of NGNE on the open market, with no buys.

Latest NGNE insider transactions
InsiderTypeSharesValue
McMinn RachelOption exercise756—
McMinn RachelOption exercise756$19.14K
Cvijic Christine MikailSale4.20K$151.76K
Cvijic Christine MikailSale600$21.61K
Cvijic Christine MikailSale1.53K$53.90K
Cvijic Christine MikailSale2.53K$87.52K
Cvijic Christine MikailSale739$25.17K
Cvijic Christine MikailSale4.80K$155.69K
Cvijic Christine MikailSale4.80K$144.35K
Shafer ChristinaAward120.00K—

Short interest

Settled Sep 30, 2026

Shares short
4.97M
Days to cover
11.73
% of shares outstanding
25.20%
Average daily volume
423.99K
Change since last report
+51.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.